Post by CERo Therapeutics, Inc.

In a new interview with Pulse 2.0, #CERoTherapeutics' CEO, Chris Ehrlich, discusses the Company's innovative CER-T cell therapy platform, the progress of the ongoing CERTAIN-T Phase 1 trial, and CERo's vision for advancing next-generation immunotherapies.   Read the full interview: https://lnkd.in/eU-_bwDK   #Immunotherapy #CellTherapy